Cancer Research
-
Stomach Cancer Surge in Under-50s: Experts Reveal Key Risk Factors
GREENVILLE, S.C., June 28 — Carly Douglas was 34 years old, a mother of three, and an influencer with 140,000 Instagram followers.…
-
Stomach Cancer Decline Reverses as Under-50 Diagnosis Rates Rise
A Reversal Decades in the Making For roughly fifty years, the news on stomach cancer was good. Cases kept falling. Better refrigeration,…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
-
Lioness Ella Toone becomes Prostate Cancer UK ambassador after father’s death
One man dies from prostate cancer every 45 minutes in the UK. That statistic, from Prostate Cancer UK, is the cold arithmetic…
-
Ella Toone becomes Prostate Cancer UK ambassador after father’s death at 59
Every 45 minutes, a man in the UK dies from prostate cancer. That statistic, from Prostate Cancer UK, is the cold arithmetic…
-
Bowel cancer survivor Adele Roberts details stoma prolapse after fundraiser
Bowel cancer survivor’s stoma struggle laid bare after charity challenge LONDON — Adele Roberts spent an entire night holding her own intestine…
-
Lymphoma Research Foundation Awards 24 New Research Grants
NEW YORK, June 17 — The Lymphoma Research Foundation, the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…
-
Montreal researchers discover SLAMF6 molecule acts as second immune switch
MONTREAL — The immune system has a self-destruct switch. Cancer cells have learned to flip it. And for years, doctors have been…
-
Montreal researchers discover SLAMF6 molecule directly shuts down immune cell defenses
MONTREAL — The molecule that shuts down the body’s cancer defenses does not need a middleman. It acts on its own. That…
-
New Pill Nearly Doubles Survival in Advanced Pancreatic Cancer
NEW YORK, June 8, 2026 — infopulsetoday.com — An experimental oral drug has nearly doubled survival in patients with advanced pancreatic cancer,…
-
Researchers Identify NFIL3 Protein as Key to CAR T-Cell Exhaustion in Tumors
NEW YORK — The engineered immune cells arrive ready to fight. They hit solid tumors hard. Then, within weeks, they stop. They…
-
CAR T-cell exhaustion switch found, disabled in mice study
In a breakthrough discovery, a team of researchers from Columbia University and University Hospital Tubingen has identified a key molecular switch responsible…
-
Tumors That Hide From the Immune System May Be More Vulnerable
HOUSTON, June 6 — A study has overturned a long-held assumption in cancer immunology, finding that tumors which hide from the immune…
-
Study Finds Cancers Hiding from T Cells May Be More Vulnerable to Immune Attack
For years, the logic seemed airtight. Cancer cells that stripped away a key molecular flag — MHC class I — were considered…
-
Study Reveals ‘Invisible’ Cancer Cells Vulnerable to New Immune Attack
For decades, the prevailing view in oncology held that cancer cells that lose MHC class I molecules become invisible to cytotoxic CD8⁺…
-
Study Reveals Hidden Tumors May Be More Vulnerable to Immune Attack
Michigan, June 6, 2026 — cybernewschronicle.com — Cancer cells that go invisible to the immune system might have just painted a target…
-
Researchers Unveil 3D Microscopy of T Cell Killing Cancer Cells
GENEVA, June 5, 2026 — infopulsetoday.com —The battle between a killer T cell and a cancer cell happens in a space smaller…
-
Scientists Capture T Cell Killing Cancer Cells in 3D Detail
Researchers at the University of Geneva, together with colleagues at CHUV and UNIL, have visualised the exact moment a human T cell…
-
Scientists Capture 3D View of Killer T Cells Attacking Cancer
GENEVA, June 5 — Scientists have captured a detailed three-dimensional view of how killer T cells attack cancer, work that could help…
-
Scientists Capture 3D View of T Cells Attacking Cancer
Geneva, 5 June – A team of researchers from the University of Geneva and the CHUV/UNIL collaboration has produced the first detailed…
-
Yale Study: Olive Oil Fat Speeds Pancreatic Cancer in Male Mice
NEW HAVEN — The olive oil praised for decades as a cornerstone of heart health may have a dangerous blind spot. New…
-
Abbott Buys Exact Sciences in $21B Cancer Deal
MADISON, Wis. — The stool DNA test sits in a box. Patients collect a sample at home, mail it to a lab,…
-
Exact Sciences Corporation
Madison, Wisconsin, November 18, 2025 — cyberinktimes.com — On November 15, 2025, a significant development occurred in the field of cancer diagnostics…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
-
Stanford Digital Twins Identify Drug Combo To Stop Premature Birth
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds